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Abstract  
Cystic fibrosis (CF), a lethal monogenic disease, is caused by mutant variants of the CF 
transmembrane conductance regulator (CFTR). Recent advances in single molecule cryo-EM methods 
enabled structural determination of full-length human and zebrafish CFTR, achieving an important 
milestone for CF drug development. To relate these structures to the gating cycle, we examined its 
dynamic features using molecular dynamics simulations. Our results show that the nucleotide binding 
domains (NBDs) in this bottom-open apo conformation exhibit motions related to dimerization and the 
bottom-closed apo CFTR model indicates opening of NBDs in contrast to transporters. These 
observations help in understanding the properties of CFTR chloride channel distinct from transporters 
and in proper interpretation of available structural information on this ABC protein. 
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Introduction 
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator 
(CFTR) protein resulting in the lack of functional expression of this chloride channel in the apical 
membrane of epithelial cells [1]. Intense efforts have been made to correct the basic defect and restore 
the functional expression of the mutant by small molecules [2,3,4]. However, drug development is still 
hampered by lack of high resolution CFTR structures.  
 CFTR is a member of the ABC protein superfamily providing an ion conductance pathway 
through the cell membrane by two TMD consisting of 6 transmembrane (TM) helices each [5,6]. It 
possesses  two nucleotide binding domains (NBDs), which bind ATP, form a transient interaction, and 
contribute strictly to regulate the channel gating and chloride ions flow along the electrochemical 
gradient [7,8]. The two composite ATP-binding sites are formed by complementary parts of the two 
NBDs at their domain-domain interface including the Walker A, Walker B and ABC signature 
sequences. [9]. ATP binding alone is not sufficient for channel opening, but requires the 
phosphorylation of the R domain as well [10]. This region is a ~200 a.a. long disordered segment 
between NBD1 and TMD2 and includes a large number of PKA and other kinase sites. 
The atomic structure of several full length ABC transporters has been determined. Currently 
four main conformations of Type I ABC exporter structures can be distinguished: (1) inward-facing, 
bottom-open (Fig. S1 a,b) and (2) inward-facing, bottom-closed conformations in the absence of ATP 
(Fig. S1 c); (3) outward-facing, bottom-closed in the presence of ATP (Fig. S1 d) and (4) a 
conformation closed both at the intracellular and extracellular sides (Fig. S1 e) [6]. Ford et al. have 
made pioneering work to uncover structural features of CFTR, investigated its domain organization, 
and structural changes upon phosphorylation and nucleotide binding by electron microscopy 
[11,12,13]. They have observed CFTR to accommodate a bottom-closed conformation in crystals [14]. 
However, the resolution of these structures is generally low (8>Å), prohibiting studies for drug 
development or understand the structural effect of mutations. 
The recent CFTR structures determined by single particle electron microscopy exhibit 
significant improvements in resolution and became the ultimate source of further studies aiming CF 
therapy. The structures of dephosphorylated zebrafish and human CFTR, which have been determined 
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in the absence of ATP [15,16], exhibit a significant distance between the two NBDs  and the two 
halves of the molecule show unexpected asymmetric features. In order to learn the role of these 3D 
features in CFTR structure and function, we assessed various properties of CFTR models and 
performed in-depth in silico analysis. 
 
Methods 
Structures. Zebrafish and human CFTR structures derived from EM maps were downloaded from the 
PDB database: (PDBIDs: 5TSI/5UAR, 5U71/5UAK) [15,16]. We also employed the CFTR homology 
models generated by Corradi et al. based on the TM287/288, McjD, and Sav1866 templates [17]. We 
call these models as CFTRTM287/288, CFTRMCJD, and CFTRSAV1866, respectively. 
 
Molecular dynamics simulations. The structural models were inserted into lipids using the 
CHARMM-GUI web interface [18,19]. Production runs at 310 K were performed after energy 
minimization and equilibration steps using GROMACS with CHARMM36 force field [20,21]. 
Simulations details can be found in the supplementary material and summarized in Table S1. Analysis 
was done by GROMACS tools, the MDAnalysis package [22] and in-house Python scripts. We 
demonstrate conformational changes by the distances between the center of mass of the two NBDs. 
Since the distance can change many ways and characterizes movements ambiguously, we also 
calculated the number of contacts formed between amino acids of the NBDs throughout the 
trajectories.  
 
Electrostatics calculations. The electrostatic property of the protein surface was calculated using the 
Adaptive Poisson-Boltzmann Solver (APBS) at http://www.poissonboltzmann.org [23,24]. 
Calculations were done using the default parameters (e.g. PARSE force field, PROPKA pH 7) except 
that a 0.15 M concentration was set for sodium (0.95 Å radius) and chloride (1.81 Å radius) ions. 
Visualization was done by the PyMOL APBS plugin (Michael Lerner). Color-coding of the 
electrostatic surface was set from -5 to +5 KbT/ec. This was done for visual comparability with earlier 
studies [15], and for solvation free energy calculations (ΔΔG=ΔGmembrane-ΔGwater) APBSmem was 
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employed with default parameters as above [25,26] and the bilayer location was defined based on 
OPM. 
 
Results 
 
The experimental CFTR structure possesses unexpected features. In the last decade the CFTR 
structure was extensively modeled based on the structure of various ABC transporters. Although key 
points of the models, such as the position of the coupling helices, have been experimentally confirmed, 
there was a doubt, whether the transmembrane helices need to exhibit a significantly different 
conformation for providing a chloride channel function compared to transport. At the first blush, the 
zfCFTR and hCFTR structures are different from the currently known conformations, exhibiting a 
one-sided humped configuration with a main protein axis not parallel with the membrane normal. 
When these CFTR structures are aligned with an ABC structure exhibiting similarly separated NBDs, 
such as the structure of mMDR1 (PDBID: 4M1M), the overlap of the secondary structural elements is 
relatively high (Fig. 1). We found that the humped-looking configuration of zfCFTR and hCFTR is the 
result of the different orientation of the membrane region compared to other ABC proteins. When the 
mMDR1 and CFTR structures are aligned, the planes of the bilayers predicted by the OPM server 
enclose an angle (Fig.1).  
[Fig. 1] 
Although most of the CFTR transmembrane helices overlap with MDR1, some of the 
differences have been claimed to be important. The TH7 is displaced from its usual position compared 
to other ABC structures,  facilitated by the unusual break in the TH8 [15] (Fig. 1).  Because of this 
break and the tilting described above, we performed surface electrostatics calculations, which indicate 
charged areas in the membrane region thus suggest structural perturbations in the transmembrane 
helices of the dephosphorylated CFTR structures (Fig. 2). We also assessed solvation free energy 
employing the Adaptive Poisson–Boltzmann Solver for membrane proteins [25]. Per residue and total 
solvation free energies were calculated for hCFTR, homology models, and the templates of the latters. 
We compared the solvation of the individual transmembrane helices (Table 1 and Fig. S2). Amino 
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acids in transmembrane helices 2, 6, 8, and 11 of hCFTR exhibit positive values. The larger values in 
TH6 in all structures can be contributed to Arg347 and Arg352, which have been shown to participate 
in the channel path [27,28]. The TH8 solvation is negative for all the homology models, while 
possesses a high positive value for the hCFTR structure. Among the structural models, hCFTR 
exhibits the highest (-77 kJ/mol), CFTRTM287/288 possesses the lowest (-259 kJ/mol) solvation free 
energy values, and the CFTRMCJD has the most transmembrane helices with negative solvation free 
energy.  
[Fig. 2] 
The potential disturbances in the TMDs of the experimental CFTR structure may question the 
conformation and the interaction of the N-terminal, approx. 80 a.a. long L0/Lasso motive with the 
TM10-11 helices.  Although the Lasso motif is not a linker region in CFTR, because of the very high 
structural similarity with ABCC1/MRP1 L0 ([29,30] and Supplementary Discussion) we suggest to 
call this segment in ABCC proteins as the L0/Lasso motif. This N-terminal region also contains amino 
acids with high solvation free energy values (Fig. S2). However, electrostatic properties of the 
transmembrane region indicate a valid arrangement of this L0/Lasso segment in the structure, since it 
is attached to a hydrophobic spot interrupting the positive ring of the transmembrane domains, located 
at the depth of the inner bilayer boundary. This ring is formed by positively charged amino acids at the 
interface region of transmembrane helices according to  the positive-inside rule [31,32] and is 
observable in the CFTR homology models, but not well-defined in the experimental structure  (Fig. 2). 
 
The inward-facing CFTR structure tends to close in molecular dynamics simulations. The non-
phosphorylated zfCFTR and hCFTR in the absence of ATP exhibit an inward-facing conformation 
with widely open NBDs. Some level of opening, even larger than that of transporters, is not 
unexpected, since the unphosphorylated R domain has been envisioned to exert its inhibitory role by 
intertwining between the NBDs [33]. However, this intertwining could also be realized in the case of 
the bottom-closed TM287/288-like conformation with partially opened domains (Supplementary 
Discussion and Figures S3 and S4). It has been claimed for supporting the large NBD separation in 
hCFTR, that reaction of MTS reagents with cysteine residues engineered into the ABC signature 
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sequence requires a large separation [15,34]. While these residues are buried in the ATP-bound 
NBD1-2 dimer, they are solvent exposed in the bottom-closed apo structure. We demonstrate their 
accessibility by MTS reagents using in silico docking simulations (Fig. S5).  
We assessed the conformation and dynamics of the NBDs in different CFTR structural models 
using molecular dynamics simulations, which have been implicated as useful tools for checking 
anomalies in membrane protein structures [35]. Serious changes in the structure, including large rigid 
body motions and loss of secondary structure has been reported to be observed even in short (~20 ns 
long) simulations in the case of non-native contacts and elements in experimentally determined 
structures [35,36]. In spite of the expectations, based on our earlier simulations with inward-facing 
structures ([36] and unpublished), not all the simulations with the bottom-open zfCFTR exhibited 
closing of the NBDs (Fig. 3). One of them remained opened and no interaction is formed between the 
two NBDs. 
[Fig. 3] 
The cryo-EM 3D single particle analysis could not resolve structural heterogeneity and all the 
particles were included for final reconstruction [15,16]. This homogeneity suggests that the hCFTR 
structure is conformationally biased, especially when the highly dynamic nature of ABC proteins is 
taken into account [37]. One possibility is that embedding the CFTR in detergent micelle during 
purification promotes the open conformation of the channel. In order to test the potential effect of a 
micelle system on the distance between the two NBDs, we created a micelle around zfCFTR and 
performed MD simulations (Fig. S6). In this system we could observe a delay in closing motions when 
compared to a lipid bilayer system. However, even simulations with non-contacting NBDs exhibit 
motions for closing revealed by essential dynamics analysis (Fig. S7). 
In order to further test the probability of the bottom-open CFTR conformation, we performed 
similar simulations with the inward-facing, bottom-closed apo CFTRTM287/288 model [17]. In two out of 
six simulations the distance between the NBDs increased and approximated the value observed in the 
zfCFTR structure, with no contacts between the two domains (Fig. 3). This was unexpected, as we 
have observed only closing NBD motions in the MDR1TM287/288 model (Fig. 3). To assess whether the 
increased dynamics of the intracellular domains is characteristic for CFTR, we performed simulations 
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with the TM287/288 structure embedded in a bilayer. None of the simulations exhibited full opening 
of the NBDs (Fig. S8). 
These results suggest that in addition to the potential promotion of the inward-facing 
conformation in the presence of the R domain and the micelle environment, repulsion and opening up 
may be intrinsic properties of CFTR NDBs that contributes to channel deactivation by exposing a 
volume for the intrusion of the dephosphorylated R domain. However, the structure widely open at the 
bottom is most likely not highly populated under physiological conditions as indicated by its exerted 
tendency to close. 
 
 
Discussion 
 
The determination of the CFTR protein structure is an important milestone in cystic fibrosis 
research.  However, the features of the current experimentally determined structures limit the 
understanding of the gating mechanism and the effect of mutations (Supplementary Discussion). The 
limitations of single molecule structure determination methods should be taken into account in the 
case of any application of the accompanying all atom models. E.g. the relative low resolution of 
certain critical CFTR regions does not allow an accurate determination of amino acid side chain 
orientation sufficient for drug development. The large distance between the NBDs of the novel CFTR 
structures draw our attention to the transmembrane domain conformation, which turned out to exhibit 
largely different angle enclosed with the membrane normal when compared to other ABC structures. 
The calculated solvation free energy also revealed larger values than those of CFTR homology models 
and other structures.  
Beside the humped conformation and a potential distortion in the TM regions, the structural 
homogeneity of CFTR single particles implies that this conformation is highly stabilized or even 
forced by some factors under experimental conditions (e.g. the micelle, the support grid [38]). We 
demonstrate that the inward-facing, bottom-open CFTR structure exhibits some level of stability in 
molecular dynamics simulations and NBDs of the inward-facing, bottom-closed CFTRTM287/288 can 
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open up. These observations suggest that the bottom-open state is populated at a low probability under 
physiological conditions and may not be required for the regulation and function of CFTR. We show 
that a smaller space between the NBDs in the CFTRTM287/288 conformation is sufficient for events (e.g. 
accessibility of MTS reagents, intertwining of R domain) which have been suggested to need a widely 
open conformation. 
It is important to emphasize that the semi-high resolution structure of the non-phosphorylated 
zfCFTR and hCFTR together with the low resolution structure of the phosphorylated and bottom 
closed CFTR do not reconcile a chloride channel pathway for the active state [14,15,16] (Fig. 4 and 
Supplementary Discussion). Several pore-forming residues (Fig. 4, colored by red and blue) and salt 
bridges stabilizing the conducting state are close to each other in the dephosphorylated structure but 
largely separated in the bottom-closed model. Green residues have been discussed as amino acids 
participating in recruitment of negative chloride ions at the extracellular sides. This conclusion may 
not be strong, since some of the yellow residues, which do not influence the properties of the chloride 
channel, have similar spatial localization and could also recruit negative ions. Since both 
conformations are compatible with some functional data, we presume that both types of conformations 
possess physiological features, but represent short-living conformations under physiological 
conditions. Similar to Corradi et al. [17] we suggest that the conducting conformation is similar to that 
of McjD with TM helices close to each other both at the bottom and the top (Fig. 4 c). Importantly, 
CFTRMCJD exhibits pathways with a lateral opening at the cytoplasmic loops and openings between the 
extracellular loops. The lateral opening of the presented pathway located between TM4 and TM6 was 
also detected in MD simulations by Mornon et al. [39,40] and incorporates K370 affecting channel 
properties. While the published experimental structures are undoubtedly important in the heroic work 
of deciphering structure/function relationships of CFTR, there is a high demand to gather further data 
on various conformers at a higher resolution and possibly under more physiological conditions (e.g. in 
nanodisc). Till then the field is highly dependent on various models built based either on the published 
electron densities or on homology. 
In the last decade CFTR homology models were used extensively to guide structure-function 
studies as discussed in a recent review by Callebaut et al. [41]. Since the homology models rely on 
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multiple sequence alignments and using numerous experimental constraints, in principle, they are 
expected to be similar to experimental structures in many specific features. Since several properties of 
the inward-facing structure are unusual and may present a sparsely populated conformation under 
physiological conditions, the CFTR homology models of various conformations and their proper 
utilization in CFTR research are still crucial. 
Our work also highlights the importance of complex in silico analysis of structural data on 
transmembrane proteins. Measures used for validate the quality of experimental structures of soluble 
proteins (e.g. ratio of disallowed dihedral angles) should be supplemented with additional methods 
assessing various properties of transmembrane regions. Taking additional measures into account for 
structure validation are likely important not only for CFTR, but for every membrane proteins.  
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Figure legends 
 
Fig. 1 Comparison of the membrane orientation of zfCFTR and mMDR1. (a) hCFTR (PDBID: 
5UAK) and mMDR1 (PDBID: 4M1M; gray) were structurally aligned and their transmembrane region 
are labeled with two layers of dots (blue and black, respectively), determined using the OPM server. 
(b) There is an unexpected break in TM8 (blue) of zfCFTR (shown here) and hCFTR. TMDs: green, 
cyan, NBDs: orange, yellow, TH8 segment: blue. 
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Fig. 2 Electrostatics calculations suggest disturbance in the TM helices, while a proper binding 
location of the L0/Lasso region. (a) Calculations performed by the APBS server (Adaptive Poisson-
Bolzman Solver and displayed in PyMOL) indicate charged residues of zfCFTR exposed to the 
hydrophobic part of the bilayer (arrows). (b) The same calculation is shown also for mMDR1. (c) 
Electrostatics at the protein surface underlines the location of the intramolecular interaction of the 
L0/Lasso motif with the core CFTRSAV1866. A positive ring can be observed as a blue collar at the level 
of the membrane inner interface disrupted by a hydrophobic patch (white) at the location of L0/Lasso 
region binding (TH10-11; arrow). Approximate bilayer boundaries are indicated by dashed lines. 
 
Fig. 3 zfCFTR in a bilayer is biased towards NBD closure, while CFTRTM287/288 opens up in MD 
simulations. Six simulations were performed with zfCFTR (PDBID: 5UAR) embedded in a POPC 
bilayer. (a) The distance of the center of mass of NBDs is shown in the top panel. The bottom panel 
shows the number of amino acid contacts (C-C <= 8 Å) between the NBDs throughout the 50 ns 
long simulations. Six simulations were performed with both CFTRTM287/288 (b) and MDR1TM287/288 (c) 
in a POPC bilayer. In two cases (black, red) the NBDs in CFTRTM287/288 got farther from each other 
and reached a distance as in zfCFTR (solid horizontal line), losing all the contacts between them. In 
the case of the MDR1 model the NBDs tended to form more contacts.  The horizontal lines show this 
value for the CFTRTM287/288 (solid) and the CFTRSAV1866 (dotted) homology models and the initial 
conformation of zfCFTR (dashed) as references. 
 
Fig. 4 It is challenging to integrate the atomic level data into the gating cycle. Inward-facing 
hCFTR (a; PDBID: 5UAK), outward-facing CFTRSAV1866 (b), and CFTRMCJD model (c) are shown in 
gray. Specific positively charged residues are shown in stick representation and colored as follows. 
Pore constriction residues (colored by red) are close to each other in the non-phosphorylated (a) and 
McjD-based (c) structures. Blue residues surrounding the large vestibule participate in constructing 
chloride pathway. Green residues have been indicated as amino acids participating in recruitment of 
negative chloride ions at the extracellular side. Cyan residues show the lateral openings suggested by 
MD simulations. Purple is one of the detected pathways.  
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Table 1 Solvation free energy of CFTR structural models calculated by APBSmem 
 Solvation free energy (kJ/mol) 
 hCFTR CFTRTM287/288 CFTRMCJD CFTRSAV1866 
templates* 
 
-226 -488 -267 
full length** -77 -259 -226 -224 
TH1 -14 28 -18 3 
TH2 2 -29 -27 -81 
TH3 -22 -40 -32 -63 
TH4 -90 -107 -87 -108 
TH5 -1 -50 -30 35 
TH6 9 73 26 13 
TH7 -61 -84 -33 -73 
TH8 61 -40 -34 -27 
TH9 -18 -51 -41 -4 
TH10 -102 -84 -77 -84 
TH11 51 50 -5 34 
TH12 -9 -18 -19 -24 
 * PDBIDs: 3QF4, 4PL0, and 2HYD 
**residues present in all CFTR structures 
 
